Nursing Diagnosis for Pneumonia: 5 Sample Care Plans & Interventions

Choosing the right nursing diagnosis for pneumonia — and building a clean NANDA-I care plan around it — is one of the most common assignments in nursing school and one of the most common conditions you’ll see on the floor. Pneumonia covers a huge clinical spectrum: the previously healthy 22-year-old with a mild community-acquired pneumonia (CAP), the 78-year-old with hospital-acquired pneumonia (HAP) and CURB-65 score of 4, the ventilator-associated pneumonia (VAP) on day 5 of intubation, the post-stroke aspiration pneumonia.

This pneumonia nursing care plan walks through what to assess, the NANDA-I nursing diagnoses for pneumonia you’ll see most often, and 5 sample care plans you can model your clinical paperwork on for the most common presentations.

It’s written for nursing students, new grads, and any RN who wants a refresher with the 2019 ATS/IDSA CAP guideline plus the 2025 ATS CAP focused update, the 2016 ATS/IDSA HAP/VAP guideline, BTS oxygen guidance, current CDC / ACIP vaccine recommendations, and Surviving Sepsis Campaign 2026 principles baked in. Always verify against the most current published edition.

Scope note. This is an educational care plan for nursing students and new graduates. It is not a substitute for facility protocol, provider orders, or specialist clinical judgment. Antibiotic selection, oxygen targets, ventilation decisions, and sepsis screening / treatment execution depend on the patient and your institution — always follow current local policy and the patient’s individualized plan.

Quick answer. The most common nursing diagnoses for pneumonia are Ineffective Airway Clearance, Impaired Gas Exchange, Hyperthermia, Risk for Sepsis (or suspected sepsis when organ dysfunction is present), and Activity Intolerance. Choose the diagnosis based on the patient’s actual assessment findings — retained secretions, hypoxemia, fever, deterioration risk, or exertional dyspnea.

Table of contents

• What is pneumonia?
• Types: CAP, HAP, VAP, aspiration
• Common pathogens
• Signs and symptoms
• Nursing assessment
• CURB-65 severity scoring
• Diagnostic studies and lab interpretation
• Antibiotic timing and stewardship
• Oxygen targets
• Nursing goals and outcomes
• Nursing interventions
• Nursing diagnosis for pneumonia — 5 sample care plans
• Sepsis bundle and red flags
• Escalation red flags
• Discharge and patient teaching
• Practice question
• FAQs
• Related resources
• References

What is pneumonia?

Pneumonia is infection and inflammation of the lung parenchyma — specifically the alveoli and the surrounding interstitium. When the alveoli fill with exudate (pus, fluid, neutrophils, fibrin, bacterial or viral debris), they can’t oxygenate effectively, creating ventilation–perfusion (V/Q) mismatch. Blood flows past poorly ventilated alveoli, so oxygenation falls. That’s why hypoxemia is the central physiological problem in moderate-to-severe pneumonia.

It’s one of the leading causes of hospitalization and death from infectious disease in the United States, particularly in older adults, immunocompromised patients, and people with chronic lung disease.

Types: CAP, HAP, VAP, aspiration

The distinction matters because empiric antibiotic choice changes by category. HAP / VAP empiric therapy covers S. aureus and gram-negative pathogens including Pseudomonas; MRSA coverage is added when risk factors are present (recent IV antibiotics, hospitalization, high or unknown local prevalence, high mortality risk). CAP regimens usually don’t cover MRSA or Pseudomonas by default.

Common pathogens

Typical CAP pathogens:

• Streptococcus pneumoniae (most common bacterial cause)
• Haemophilus influenzae
• Moraxella catarrhalis
• Staphylococcus aureus (post-influenza superinfection)

Atypical CAP pathogens:

• Mycoplasma pneumoniae — younger adults, “walking pneumonia”
• Chlamydia pneumoniae
• Legionella pneumophila — water-source exposure, GI symptoms, hyponatremia, relative bradycardia; can present severely

Viral:

• Influenza A and B
• RSV (rising adult disease burden)
• SARS-CoV-2
• Parainfluenza, adenovirus, human metapneumovirus

HAP / VAP pathogens (broader, often resistant):

• MRSA
• Pseudomonas aeruginosa
• Extended-spectrum beta-lactamase (ESBL) producers
• Acinetobacter, Stenotrophomonas in select settings

Aspiration pneumonia:

• Treated based on severity, setting, and risk factors. Routine anaerobic coverage is not recommended unless lung abscess, empyema, necrotizing infection, or another anaerobic source is suspected.
• Chemical pneumonitis from acid alone is treated supportively first; antibiotics are added if bacterial superinfection develops.

Signs and symptoms

The data below is what to consider, not what every patient with pneumonia will have. Older adults and the immunocompromised may present atypically (delirium without fever; falls; decreased PO intake).

Cardinal signs:

• Cough (productive in bacterial; often dry in atypical / viral)
• Sputum (purulent / mucopurulent in bacterial; scant or none in atypical)
• Fever, chills, rigors
• Dyspnea, tachypnea
• Pleuritic chest pain
• Crackles, rhonchi, or bronchial breath sounds over the affected lobe
• Egophony, increased fremitus over consolidation
• Decreased SpO₂

Older-adult / atypical presentations:

• New confusion or delirium (often the only sign)
• Falls
• Decreased PO intake
• Worsening of baseline disease (CHF, COPD)
• Older adults may lack fever or present atypically — confusion or functional decline can be the only sign

Legionella-specific:

• Diarrhea, GI symptoms
• Relative bradycardia (HR lower than expected for the fever)
• Hyponatremia
• Confusion

Nursing assessment

A solid assessment is what makes the difference between a generic care plan and one with the right nursing diagnosis for pneumonia attached to it. Use a structured approach.

Subjective data

• Onset and duration of cough, sputum, fever, dyspnea
• Pre-existing conditions — COPD, asthma, CHF, immunosuppression, malignancy
• Recent hospitalization, antibiotic exposure, nursing-home stay → think HAP / multidrug-resistant
• Travel, environmental exposure (Legionella from cooling towers, hot tubs, hotel stays)
• Vaccination status — pneumococcal, influenza, COVID-19, RSV
• Smoking and alcohol history
• Aspiration risk — recent stroke, swallowing difficulty, NPO status, recent anesthesia
• Functional baseline — what could the patient do before this illness?

Objective data

• Vital signs — HR, BP, RR, T, SpO₂; capnography if intubated
• Respiratory exam — accessory muscle use, work of breathing, lung auscultation (crackles, rhonchi, decreased breath sounds, bronchial sounds, egophony)
• Sputum — color, volume, viscosity; teaching color alone is not enough to distinguish bacterial from viral
• Cardiac — heart sounds, peripheral perfusion
• Neuro — alertness, orientation (new confusion in older adults is a major red flag)
• Skin — color, capillary refill
• Hydration — mucous membranes, skin turgor, intake/output

Avoid absolute language. “Crackles auscultated in the right lower lobe” is more useful than “patient has bad pneumonia.” Document what you observe.

CURB-65 severity scoring

CURB-65 is a quick bedside tool for CAP severity. Each finding = 1 point.

Interpretation (guide, not absolute):

Clinical judgment, social factors, oxygen needs, and comorbidities can override the score. PSI (Pneumonia Severity Index) is the more granular tool used in some settings — it considers more variables but takes longer to calculate.

Diagnostic studies and lab interpretation

Reference ranges vary by lab — check facility normals.

Antibiotic timing and stewardship

General principles (verify with facility protocol):

• Do not delay empiric antibiotics in moderate, severe, or clinically unstable pneumonia while waiting for culture results. Antibiotic timing and duration follow facility protocol, provider orders, severity, microbiology, and clinical stability.
• Per Surviving Sepsis Campaign 2026: administer antimicrobials within 1 hour for septic shock or probable/definite sepsis; rapid time-limited investigation is appropriate for possible sepsis without shock.
• Collect cultures rapidly when feasible; do not delay therapy for cultures in severely ill patients.
• Empiric CAP coverage typically combines a beta-lactam (e.g., ceftriaxone, ampicillin-sulbactam) with a macrolide (azithromycin) or a respiratory fluoroquinolone (levofloxacin) for ICU-level disease — exact regimens are local and patient-specific.
• HAP / VAP empiric therapy should cover S. aureus and gram-negative pathogens including Pseudomonas. MRSA coverage is risk-based — added when risk factors are present (recent IV antibiotics, hospitalization, local MRSA prevalence high or unknown, high mortality risk).
• Duration: The 2025 ATS CAP focused update supports shorter individualized courses (often < 5 days, minimum ~3 days) for clinically stable nonsevere CAP. Severe CAP generally requires longer treatment (≥ 5 days). Complicated, immunocompromised, or specific-pathogen infections per provider.
• De-escalate as soon as cultures and clinical course allow; procalcitonin trends can support shorter courses.
• Stewardship principles — the right drug, the right dose, the right duration; routinely involve pharmacy and ID when needed.

Oxygen targets

Per the BTS Emergency Oxygen Guideline:

• Use the lowest FiO₂ that meets the target.
• High-flow nasal cannula (HFNC) is increasingly used for moderate-severe hypoxemia before non-invasive or invasive ventilation.
• Non-invasive ventilation (BiPAP) helps acute hypercapnic respiratory failure in COPD with pneumonia overlap; it’s a provider decision.
• Mechanical ventilation per provider for progressive respiratory failure, exhaustion, or sepsis-related shock.

Nursing goals and outcomes

Once you’ve picked the nursing diagnosis for pneumonia that fits the patient’s actual presentation, your goals flow directly from it. By the end of the shift / hospitalization, the patient will (choose what fits):

• Maintain SpO₂ within the individualized target range (typically 94–98% per BTS for most acutely ill adults; 88–92% for hypercapnic-risk patients pending ABG/VBG).
• Maintain RR within their normal range and decreased work of breathing.
• Effectively mobilize secretions — productive cough, clearing rhonchi, improving CXR.
• Maintain body temperature within an acceptable range with antipyretics and treatment.
• Show no signs of clinical deterioration toward sepsis or ARDS.
• Verbalize understanding of antibiotic course, follow-up plan, vaccine status, and red flags.
• Demonstrate progressive activity tolerance during recovery.
• Identify three early warning signs that warrant a return to care.

Use SMART framing and add function-based goals — “ambulates to bathroom and back without SpO₂ drop below 92%” is more useful than “tolerates activity.”

Nursing interventions

Oxygenation and ventilation

• Position upright (HOB ≥ 30°, often 45° when tolerated); side-lying with the “good lung down” can improve V/Q matching in unilateral disease.
• Apply supplemental oxygen to target SpO₂ per provider order; use the lowest FiO₂ that meets the target.
• Monitor work of breathing — accessory muscle use, paradoxical abdominal motion, tripoding, single-word dyspnea.

Airway clearance

• Encourage cough and deep breathing every 1–2 hours while awake.
• Incentive spirometry is part of a pulmonary hygiene bundle (per AARC 2011) — it is not a stand-alone prophylactic.
• Adequate hydration thins secretions when not contraindicated by HF or volume overload.
• Chest physiotherapy is selective — used in patients with retained secretions, bronchiectasis, cystic fibrosis; not routine for uncomplicated CAP.

Medication administration

• Administer empiric antibiotics per provider order — first dose ≤ 4 hours for moderate-severe CAP; within 1 hour if sepsis bundle activated.
• Coordinate sputum and blood cultures before antibiotics when feasible without delaying therapy.
• Administer antipyretics (acetaminophen) per provider order; teach about fever as part of the immune response — comfort, not eradication, is the goal.
• Bronchodilators (albuterol, ipratropium) when bronchospasm is present.

Sepsis screening

• Watch q-SOFA at the bedside — RR ≥ 22, altered mental status, SBP ≤ 100; 2 of 3 prompts sepsis evaluation.
• Trend lactate and obtain blood cultures per protocol.
• Activate the Hour-1 sepsis bundle when criteria are met.

Aspiration precautions (for at-risk patients — post-stroke, post-op, NPO, sedated)

• HOB ≥ 30° during and after feeding.
• Swallow screen by RN; formal swallow eval by SLP if at risk.
• Oral hygiene q4–6 h reduces VAP risk in intubated patients.

Education

• Reinforce antibiotic adherence, return precautions, smoking cessation, and vaccine status — pneumococcal (PCV20 or PCV15 + PPSV23 for adults ≥ 65 per ACIP), annual influenza, age-appropriate RSV (≥ 75, or 60–74 with risk factors), COVID-19 per current ACIP.
• For deeper foundational reading, see our nursing diagnosis guide and nursing interventions overview.

Nursing diagnosis for pneumonia — 5 sample care plans

These five care plans cover the nursing diagnoses for pneumonia you’ll see most often in clinical paperwork. Each uses NANDA-I–aligned educational language, current guidance (IDSA/ATS 2019 CAP with the 2025 ATS focused update, IDSA/ATS 2016 HAP/VAP, BTS oxygen, Surviving Sepsis Campaign 2026), and the standard student template (diagnosis → defining characteristics / risk factors → goals → interventions with rationales → evaluation).

NANDA-I label verification. These examples use NANDA-I–aligned educational language. Verify exact diagnosis labels, definitions, defining characteristics, and related / risk factors in the licensed NANDA-I 2024–2026 text required by your school or facility before using these for graded paperwork or institutional documentation.

Care Plan #1 — Ineffective Airway Clearance

The most-used nursing diagnosis for pneumonia. It applies to nearly any pneumonia patient with productive cough, retained secretions, or weak cough effort.

Scenario. A 71-year-old man, 5-day history of productive cough with thick yellow-green sputum, fevers to 38.9 °C, increasing dyspnea. Admitted with CAP. RR 26, SpO₂ 89% on room air → 94% on 4 L NC. Lungs: rhonchi throughout right lower lobe, crackles bilateral lower lobes. CURB-65 = 2 (age ≥ 65 + new confusion) — RR 26 does not meet the CURB-65 RR criterion of ≥ 30. Admitted to medical floor.

Diagnosis (NANDA-I–aligned)

Ineffective Airway Clearance related to retained tracheobronchial secretions, weakened cough effort, and inflammatory exudate in the alveoli secondary to community-acquired pneumonia, as evidenced by patient-reported productive cough with mucopurulent yellow-green sputum, rhonchi throughout the right lower lobe, RR 26, and SpO₂ 89% on room air.

Goals

• Within 2 hours, the patient maintains SpO₂ within the individualized target (typically ≥ 94% per BTS for adults not at hypercapnic risk; ≥ 90% per facility protocol for hypercapnic-risk patients) on supplemental oxygen and demonstrates effective cough technique.
• Within 24 hours, breath sounds clear in the affected lung fields with improved sputum mobilization.
• Pre-discharge, the patient verbalizes airway-clearance strategies, return precautions, and antibiotic completion plan.

Interventions and rationales

Evaluation

• Did the patient maintain SpO₂ within the individualized target and demonstrate effective cough?
• Did rhonchi resolve in the affected lung field?
• Did the patient teach back airway-clearance strategies?

Care Plan #2 — Impaired Gas Exchange

Common in moderate-to-severe pneumonia. The pathophysiology — alveolar consolidation → V/Q mismatch → hypoxemia — is the central problem in significant pneumonia.

Scenario. A 64-year-old woman with severe CAP, lobar consolidation on CXR. SpO₂ 86% on room air, 93% on 6 L NC. RR 32, accessory muscle use. ABG: pH 7.45, PaO₂ 58 mm Hg, PaCO₂ 32, PaO₂/FiO₂ 138 — concerning for severe oxygenation impairment; evaluate for ARDS if bilateral infiltrates, acute onset (≤ 7 days), and noncardiogenic respiratory failure criteria are present per the Berlin definition. Lactate 2.4.

Diagnosis (NANDA-I–aligned)

Impaired Gas Exchange related to alveolar consolidation, ventilation–perfusion mismatch, and inflammatory exudate secondary to severe community-acquired pneumonia, as evidenced by SpO₂ 86% on room air, PaO₂ 58 mm Hg, RR 32, accessory muscle use, and tachycardia.

Goals

• Within 1 hour, the patient maintains SpO₂ within the individualized target (typically ≥ 94% per BTS for adults not at hypercapnic risk) on supplemental oxygen with decreasing work of breathing.
• Within 24 hours, PaO₂/FiO₂ improves with no progression to invasive ventilation requirement.
• Throughout the admission, the patient is screened for ARDS, sepsis, and ventilation needs at each shift.

Interventions and rationales

Evaluation

• Did SpO₂ meet target and work of breathing improve?
• Was the patient screened appropriately for ARDS and sepsis?
• Was escalation timely if needed?

Care Plan #3 — Hyperthermia

A common, NCLEX-friendly nursing diagnosis for pneumonia. Fever is part of the immune response but causes discomfort and increases metabolic demand and fluid loss.

Scenario. A 28-year-old patient admitted with CAP, T 39.4 °C, HR 110, BP 118/74, rigors. Cultures drawn, antibiotics given. Patient reports feeling “freezing” with chills.

Diagnosis (NANDA-I–aligned)

Hyperthermia related to infectious process (community-acquired pneumonia) and inflammatory response, as evidenced by T 39.4 °C, tachycardia, rigors, and patient-reported chills.

Goals

• Within 4 hours of antipyretic administration, the patient’s temperature decreases by at least 1 °C with improved comfort.
• Throughout the admission, the patient maintains adequate hydration and avoids dehydration / electrolyte derangement related to fever.
• The patient verbalizes understanding that fever is part of the immune response and that comfort, not zero fever, is the goal of antipyretic therapy.

Interventions and rationales

Evaluation

• Did temperature respond to antipyretics?
• Did hydration status remain adequate?
• Did the patient teach back the fever-comfort goal?

Care Plan #4 — Suspected Sepsis / Risk for Sepsis Progression

Pneumonia is a leading cause of sepsis. Catching the transition early — and activating the sepsis pathway — is one of the highest-impact nursing actions on a med-surg floor.

Scenario. A 76-year-old with multilobar CAP, day 2 of admission. New confusion (baseline alert), HR 116, BP 96/58, RR 24, T 38.7 °C, SpO₂ 91% on 3 L. Lactate 3.2. Facility sepsis screen positive. Bedside RN escalates.

Diagnosis (NANDA-I–aligned)

Priority problem: suspected sepsis requiring immediate escalation. Whether your school or facility documents this as a NANDA-I–aligned Risk for Sepsis label (when used as a deterioration-watch problem) or as an actual nursing diagnosis (when defining characteristics like new confusion, hypotension, oliguria, or lactate elevation are present), the priority is the same — activate the sepsis pathway. Suggested educational language: Risk for Sepsis Progression (or Suspected Sepsis) related to active multilobar pneumonia, advanced age, hemodynamic and laboratory warning signs (HR > 110, SBP < 100, lactate 3.2), and new altered mental status. If your program documents an actual nursing diagnosis when organ-dysfunction defining characteristics are present, document those characteristics explicitly.

Goals

• Within 1 hour of recognition, the facility sepsis pathway is activated — lactate, blood cultures × 2 when feasible, antimicrobials per severity-based timing (within 1 hour for septic shock or probable/definite sepsis per SSC 2026), IV crystalloid for sepsis-induced hypoperfusion (30 mL/kg within the first 3 hours) with reassessment, vasopressors for MAP < 65 mm Hg not responding to fluids.
• Within 6 hours, the patient maintains MAP ≥ 65 mm Hg, lactate trends down, and organ function stabilizes.
• The patient is upgraded to a higher level of care per facility criteria and provider order.

Interventions and rationales

Evaluation

• Was the facility sepsis pathway activated with severity-appropriate antimicrobial timing?
• Did MAP, lactate, mental status, and urine output meet goals?
• Was ICU evaluation completed when indicated?

Care Plan #5 — Activity Intolerance

Common in the convalescent phase of pneumonia and post-hospitalization. Even after labs normalize, patients often struggle with dyspnea on exertion for weeks.

Scenario. A 58-year-old patient hospital day 4 of CAP, antibiotic course continuing, lab markers improving (WBC 11 from 19, lactate normal). Reports dyspnea after walking from the bed to the chair. SpO₂ 95% at rest, 91% with that activity.

Diagnosis (NANDA-I–aligned)

Activity Intolerance related to imbalance between oxygen supply and demand secondary to recovering pneumonia and resulting deconditioning, as evidenced by patient-reported dyspnea on minimal exertion and SpO₂ drop > 4% with activity.

Goals

• Within the shift, the patient ambulates progressively (bed → chair → hallway) without SpO₂ dropping below the individualized target (typically 94% per BTS for adults not at hypercapnic risk) and HR climbing > 20% above resting.
• Before discharge, the patient identifies three energy-conservation strategies and a graded return-to-activity plan.
• The patient verbalizes signs that warrant a call to the provider (worsening dyspnea, return of cough/sputum/fever, decreased exercise tolerance).

Interventions and rationales

Evaluation

• Did the patient meet activity goals without breaching SpO₂ or HR limits?
• Did the patient teach back energy-conservation strategies?
• Was follow-up scheduled and vaccines updated as appropriate?

Sepsis bundle and red flags

A quick bedside reference because pneumonia patients can deteriorate fast.

Sepsis screening (per Surviving Sepsis Campaign 2026): Use your facility-approved sepsis screening tool (e.g., NEWS2, MEWS, SIRS, or your organization’s pathway). qSOFA can support escalation but should not be the sole screening tool per SSC 2026. The components below are useful bedside cues but are not a stand-alone screen:

• Respiratory rate ≥ 22
• Altered mental status
• Systolic BP ≤ 100 mm Hg

Sepsis pathway essentials (SSC 2026):

1. Measure lactate; re-measure if initial > 2 mmol/L
2. Obtain blood cultures × 2 before antibiotics when feasible
3. Administer antimicrobials within 1 hour for septic shock or probable/definite sepsis; rapid time-limited investigation is appropriate for possible sepsis without shock
4. Begin 30 mL/kg IV crystalloid within the first 3 hours for sepsis-induced hypoperfusion or septic shock, with reassessment
5. Apply vasopressors for MAP < 65 mm Hg unresponsive to fluids
6. Reassess frequently; escalate level of care early

Time matters. The timing windows are from sepsis recognition, not from arrival.

Escalation red flags

Discharge and patient teaching

Practice question

The nurse is caring for a 72-year-old patient admitted with community-acquired pneumonia. CURB-65 = 3 (age + confusion + RR 30), SpO₂ 89% on room air, T 38.9 °C, BP 102/64. Which nursing actions are appropriate? (Select all that apply.)

• A. Administer supplemental oxygen to target SpO₂ 94–98% (or 88–92% if hypercapnic-risk)
• B. Withhold antibiotics until sputum culture results return
• C. Activate facility sepsis screening (use NEWS2 / MEWS / SIRS or facility tool) and obtain lactate and blood cultures
• D. Position the patient upright (HOB ≥ 30°)
• E. Apply chest physiotherapy three times daily as routine prophylaxis

Answer: A, C, D.

• A — SpO₂ 89% is below target; supplemental oxygen to BTS target (94–98% for most adults; 88–92% for hypercapnic-risk) is appropriate.
• C — CURB-65 = 3 with confusion and tachypnea warrants sepsis screening using the facility-approved tool; lactate and blood cultures support pathway activation.
• D — Upright positioning optimizes lung expansion and V/Q matching.
• B — In moderate-severe CAP, antibiotics should not be delayed for cultures. Collect rapidly, then administer empirically within 4 hours (or within 1 hour if sepsis bundle activated).
• E — Routine chest physiotherapy is not indicated for uncomplicated CAP; it’s selective (bronchiectasis, cystic fibrosis, retained secretions in specific patients) per AARC.

FAQs

What is the most common nursing diagnosis for pneumonia?

Ineffective Airway Clearance is the most commonly used nursing diagnosis for pneumonia patients with productive cough and retained secretions. Impaired Gas Exchange is used in moderate-to-severe disease with hypoxemia. Hyperthermia, Risk for Sepsis (or suspected sepsis when organ dysfunction is present), and Activity Intolerance are also commonly used depending on the patient’s presentation. These are NANDA-I–aligned educational labels — verify exact wording against the licensed NANDA-I 2024–2026 text required by your school or facility.

What’s the difference between CAP, HAP, and VAP?

CAP (community-acquired pneumonia) is acquired outside the hospital or within 48 h of admission. HAP (hospital-acquired pneumonia) develops ≥ 48 h after admission and was not present on admission. VAP (ventilator-associated pneumonia) develops ≥ 48 h after endotracheal intubation. The distinction matters because HAP and VAP empiric therapy covers S. aureus and gram-negatives including Pseudomonas; MRSA coverage is added when risk factors are present. CAP regimens usually don’t cover MRSA or Pseudomonas by default.

What is CURB-65 and how is it used?

CURB-65 is a bedside severity score for CAP — one point for each of: new Confusion, Urea (BUN) > 20 mg/dL, Respiratory rate ≥ 30, Blood pressure (SBP < 90 or DBP ≤ 60), age ≥ 65. Score 0–1 generally outpatient; 2 consider admission; ≥ 3 consider admission with ICU evaluation if 4–5. It’s a guide — clinical judgment, comorbidities, and social factors can override.

How quickly should antibiotics be given?

Do not delay empiric antibiotics in moderate, severe, or clinically unstable pneumonia while waiting for cultures. Per Surviving Sepsis Campaign 2026, administer antimicrobials within 1 hour for septic shock or probable / definite sepsis; rapid time-limited investigation is appropriate for possible sepsis without shock. The 2025 ATS CAP focused update also supports shorter individualized treatment courses (often < 5 days, minimum ~3 days) for clinically stable nonsevere CAP, with severe CAP generally requiring longer treatment. Always follow facility protocol and provider orders.

What SpO₂ should I target?

For most acutely ill adults not at risk of hypercapnic respiratory failure, 94–98% is the target per the BTS Emergency Oxygen Guideline. For patients at risk of hypercapnic respiratory failure (COPD overlap, severe obesity / OSA, neuromuscular disease, kyphoscoliosis), target 88–92% pending ABG/VBG and provider direction. Always use the lowest FiO₂ that meets the target, and follow facility policy and provider orders.

Which vaccines prevent pneumonia?

Per ACIP: pneumococcal vaccines (PCV20 OR PCV15 + PPSV23 for adults ≥ 65 or high-risk), annual influenza, RSV vaccine (≥ 75, or 60–74 with risk factors), and COVID-19 vaccines per current ACIP recommendations. Children follow a separate pediatric pneumococcal schedule.

Related resources

• Nursing Diagnosis — full NANDA-I guide
• Nursing Interventions — independent, dependent, collaborative interventions explained
• Nursing Care Plan Template — fillable template you can adapt for any patient
• Nursing Process — the 5-step framework refresher
• ADPIE — Assessment, Diagnosis, Planning, Implementation, Evaluation
• Ineffective Airway Clearance Nursing Care Plan — companion care plan with deeper airway-management detail
• Decreased Cardiac Output Nursing Diagnosis — companion for severe pneumonia with hemodynamic compromise

References

1. Herdman TH, Kamitsuru S, Lopes CT (eds). NANDA International Nursing Diagnoses: Definitions and Classification, 13th ed., 2024–2026. Thieme. https://nanda.org/
2. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-Acquired Pneumonia. An Official Clinical Practice Guideline of the ATS and IDSA (2019). American Journal of Respiratory and Critical Care Medicine. https://www.atsjournals.org/doi/10.1164/rccm.201908-1581ST
3. Kalil AC, Metersky ML, Klompas M, et al. Management of Adults with Hospital-Acquired and Ventilator-Associated Pneumonia: 2016 Clinical Practice Guidelines by the IDSA and ATS. Clinical Infectious Diseases. https://academic.oup.com/cid/article/63/5/e61/2237650
4. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Critical Care Medicine. https://journals.lww.com/ccmjournal/Fulltext/2021/11000/Surviving_Sepsis_Campaign__International.21.aspx
5. O’Driscoll BR, Howard LS, Earis J, Mak V. BTS Guideline for Oxygen Use in Adults in Healthcare and Emergency Settings. Thorax. https://thorax.bmj.com/content/72/Suppl_1/ii1
6. Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. https://jamanetwork.com/journals/jama/fullarticle/1160659
7. Centers for Disease Control and Prevention. Pneumonia. https://www.cdc.gov/pneumonia/index.html
8. Centers for Disease Control and Prevention / ACIP. Pneumococcal Vaccine Recommendations. https://www.cdc.gov/vaccines/vpd/pneumo/index.html
9. National Library of Medicine (NCBI Bookshelf). Pneumonia (Nursing). https://www.ncbi.nlm.nih.gov/books/NBK568711/
10. American Association for Respiratory Care. Clinical Practice Guideline: Effectiveness of Pharmacologic Airway Clearance Therapies in Hospitalized Patients (Suctioning 2022; IS 2011; Adult Oxygen 2022). https://www.aarc.org/resources/clinical-resources/clinical-practice-guidelines/

Source notes. NANDA-I diagnoses, definitions, defining characteristics, and related / risk factors should be verified in the licensed NANDA-I 2024–2026 text before clinical documentation. ATS/IDSA, BTS oxygen, Surviving Sepsis Campaign, and ACIP recommendations are updated periodically — cite the most current edition.